# Albuminuria as a Key Factor Associated with Ambulatory Arterial Stiffness: A Hierarchical Multivariable Analysis

**Authors:** Kemal Ozan Lule, Ozge Ozsoy, Omer Yildirim, Hamit Yildiz

PMC · DOI: 10.3390/jcm15041498 · 2026-02-14

## TL;DR

This study finds that albuminuria is strongly linked to arterial stiffness, suggesting it could help assess heart and kidney risks early.

## Contribution

The study identifies albuminuria as a key non-hemodynamic factor independently associated with arterial stiffness after adjusting for multiple variables.

## Key findings

- Ambulatory arterial stiffness index (AASI) was significantly higher in hypertensive individuals.
- Albuminuria (uACR) was independently associated with AASI in fully adjusted models.
- Age and blood pressure parameters remained significant predictors of AASI across all models.

## Abstract

Background: The ambulatory arterial stiffness index (AASI) is a non-invasive surrogate marker of arterial stiffness; however, the relative contributions of hemodynamic, cardiometabolic, and renal factors to the AASI remain incompletely understood. This study aimed to identify the independent clinical factors associated with the AASI. Methods: This retrospective cross-sectional study included 290 individuals aged 18–65 years who underwent ABPM between 2020 and 2024. Participants were classified as hypertensive or normotensive based on ABPM criteria. Hemodynamic parameters, cardiometabolic indices, and renal biomarkers, including the urine albumin-to-creatinine ratio (uACR), were assessed. Results: Associations between the AASI and clinical variables were evaluated using the following correlation analyses and hierarchical multivariable linear regression models: Model 1-1b (hemodynamic), Model 2 (hemodynamic plus cardiometabolic) and Model 3 (hemodynamic plus cardiometabolic plus renal). The AASI was significantly higher in hypertensive individuals compared with normotensive controls. In correlation analyses, the AASI was positively associated with age, systolic blood pressure parameters, atherogenic lipid indices, and uACR and negatively associated with diastolic blood pressure parameters and the estimated glomerular filtration rate (eGFR). In multivariable regression analyses, age, maximum systolic blood pressure, and maximum diastolic blood pressure remained independently associated with the AASI across models. uACR was also independently associated with the AASI in the fully adjusted model. Conclusions: The AASI is primarily associated with hemodynamic load and age-related vascular changes. Among non-hemodynamic factors, albuminuria demonstrated the strongest association with the AASI after multivariable adjustment. These findings suggest the potential clinical value of the AASI as a practical marker for early cardiorenal risk assessment using routine ABPM data.

## Full-text entities

- **Genes:** ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, AIP (AHR interacting HSP90 co-chaperone) [NCBI Gene 9049] {aka ARA9, FKBP16, FKBP37, PITA1, SMTPHN, XAP-2}
- **Diseases:** vascular damage (MESH:D057772), insulin resistance (MESH:D007333), renal involvement (MESH:C565423), Chronic Kidney Disease (MESH:D051436), rheumatologic disorders (MESH:D012216), infection (MESH:D007239), cardiovascular and renal complications (MESH:D002318), malignancy (MESH:D009369), diabetes mellitus (MESH:D003920), valvular heart disease (MESH:D006349), atrial fibrillation (MESH:D001281), endothelial dysfunction (MESH:D014652), atherogenic dyslipidemia (MESH:D050171), deaths (MESH:D003643), Hypertension (MESH:D006973), arterial stiffness (MESH:C566112), arterial hypertension (MESH:D000081029), atherogenic (MESH:D050197), cardio-renal (MESH:D059347), Inflammatory (MESH:D007249), injury to (MESH:D014947), metabolic syndrome (MESH:D024821), Albuminuria (MESH:D000419), microvascular damage (MESH:D017566), systole (MESH:D000092244), AASI (MESH:D051346), renal and vascular damage (MESH:D007674), cardiac arrhythmias (MESH:D001145), organ damage (MESH:D000092124)
- **Chemicals:** triglyceride (MESH:D014280), potassium (MESH:D011188), TG (MESH:D013866), sodium (MESH:D012964), TyG (-), cholesterol (MESH:D002784), glucose (MESH:D005947), creatinine (MESH:D003404), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12941870